MP74-04 SEXUAL DYSFUNCTION AND LOWER URINARY TRACT SYMPTOMS IN STREET KETAMINE ABUSERS

Abstract

You have accessJournal of UrologySexual Function/Dysfunction: Evaluation II1 Apr 2018MP74-04 SEXUAL DYSFUNCTION AND LOWER URINARY TRACT SYMPTOMS IN STREET KETAMINE ABUSERS chao-tse hung, shang-jen chang, stephen shei-dei yang, and Yi-Ju chen chao-tse hungchao-tse hung More articles by this author , shang-jen changshang-jen chang More articles by this author , stephen shei-dei yangstephen shei-dei yang More articles by this author , and Yi-Ju chenYi-Ju chen More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2388AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To evaluate sexual dysfunction and lower urinary tract symptoms (LUTS) in street ketamine abusers. METHODS Street ketamine abusers caught by policemen were invited to answer the structured questionnaires including demographic data, history of drug abuse, international prostate symptom score (IPSS), interstitial cystitis symptoms and quality index (ICSI and ICQI). In addition, international index of erectile function (IIEF-5) was answered by men and female sexual function index (FSFI) by women. RESULTS In two years, 1091 subjects were enrolled with a mean age of 27.44 ±6.17 years and male/ female ratio of 894/197. Combined use of other psychoactive substance was reported in 15.1%. Mean duration of ketamine abuse and period of quitting ketamine were 31.8±36.3 and 10.9±16.9 months, respectively. Of them 245 (30%) admitted still using ketamine, 158 (19.4%) 99 (12.2%), 313 (38.4%) claimed quitting ketamine for <3, 3-6, and >6 months, respectively. Among all subjects, mean score of IPSS, ICSI, ICPI, IIEF and FSFI were 2.83 ±4.57, 1.65 ±2.51, 1.47 ±2.94, 22.35 ±3.94, 23.80 ±4.89, respectively. Score of IPSS, ICSI and IPSS were statistically related to duration of ketamine use (?12 vs. >12 months), mean daily dose (?2 vs. >2 gm), and duration of quitting from ketamine (in use vs. ?3, 3-6, >6 months). IIEF and FSFI were not statistically related to the aforementioned cutoff points. IPSS ?8 was observed in 102 (10.4%) of 977 subjects who replied questionnaire completely. Multivariate analysis showed that risk factors for elevated IPSS were duration of ketamine abuse >12 months, daily dose >2gm, and quitting ketamine <3 months (table 1). IIEF ?21 was noted in 188 (28.5%) of 659 men who completed the questionnaire completely. Less chance of low IIEF was statistically observed only in the men who quitted ketamine for 3-6 months (table 2). FSFI ?26.55 was reported in 51 (68.9%) of 74 women who replied the questionnaire completely. No significant risk factor for low FSFI was observed. CONCLUSIONS Possible male and female sexual dysfunction was observed in 28.5% and 68.9%) of male and female ketamine abusers, which were higher than those reported in healthy men and women of the same age (12-18%% and 40%, respectively). While moderate LUTS of higher was observed in only 10.4% of ketamine abusers. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1001 Advertisement Copyright & Permissions© 2018MetricsAuthor Information chao-tse hung More articles by this author shang-jen chang More articles by this author stephen shei-dei yang More articles by this author Yi-Ju chen More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...